Triple

T9806883
Position Surface form Disambiguated ID Type / Status
Subject Chugai Pharmaceutical E238175 entity
Predicate hasJapaneseName P9882 FINISHED
Object 中外製薬株式会社 E238175 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: 中外製薬株式会社 | Statement: [Chugai Pharmaceutical, hasJapaneseName, 中外製薬株式会社]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: 中外製薬株式会社
Context triple: [Chugai Pharmaceutical, hasJapaneseName, 中外製薬株式会社]
  • A. Mitsubishi Tanabe Pharma
    Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
  • B. Chugai Pharmaceutical chosen
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • C. Takeda Pharmaceutical Company
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • D. Sankyo Company
    Sankyo Company is a Japanese pharmaceutical firm known for its role in developing cholesterol-lowering statin drugs and later becoming part of Daiichi Sankyo.
  • E. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ca84defac48190abc1148804f184c1 completed March 30, 2026, 2:12 p.m.
NER Named-entity recognition batch_69cdab7cb9588190953a063cb7b9e29e completed April 1, 2026, 11:34 p.m.
NED1 Entity disambiguation (via context triple) batch_69d1c45a84d08190a7b5769d4a489b35 completed April 5, 2026, 2:09 a.m.
Created at: March 30, 2026, 8:29 p.m.